SCHEMBL20133753

SCHEMBL20133753

Cc1cccc(N2CCN(C(=O)c3cc(NC4CCN(c5ccccc5Cl)CC4)c(C)cc3C)CC2)n1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTOR P42345 4/20 0.53
RPTOR Q8N122 4/20 0.53
MLST8 Q9BVC4 4/20 0.53
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
GBA1 P04062 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
GAA P10253 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HSP90AA1 P07900 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPK1 P28482 2/20 0.42
TP53 P04637 1/20 0.41
KRAS P01116 1/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
DCTPP1 Q9H773 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20133647 0.84 MTOR (0.58) MTORRPTORMLST8SMN1; SMN2GAA
SCHEMBL20133751 0.83 MTOR (0.72) MTORRPTORMLST8SMN1; SMN2GAA
SCHEMBL22693096 0.82 MTOR (0.43) MTORRPTORMLST8RAB9ANPC1
SCHEMBL20141569 0.80 RAB9A (0.46) MTORRPTORMLST8RAB9ANPC1
SCHEMBL20150037 0.80 MTOR (0.51) MTORRPTORMLST8NPC1SMN1; SMN2
SCHEMBL20133703 0.80 MTOR (0.49) MTORRPTORMLST8SMN1; SMN2GAA
SCHEMBL20133559 0.80 MTOR (0.54) MTORRPTORMLST8SMN1; SMN2ALDH1A1
SCHEMBL20133702 0.78 MTOR (0.47) MTORRPTORMLST8RAB9ANPC1
SCHEMBL20150152 0.78 MTOR (0.67) MTORRPTORMLST8SMN1; SMN2ALDH1A1
SCHEMBL20133739 0.78 MTOR (0.78) MTORRPTORMLST8GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2020-07-02 US disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 US disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.